We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Novartis AG | NYSE:NVS | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.51 | -0.50% | 100.60 | 100.65 | 100.065 | 100.29 | 553,344 | 17:29:10 |
From May 2023 to May 2024
By Adria Calatayud
Novartis's off-patent medicines division Sandoz said Thursday that it plans to move to new headquarters next year, but remain based in Basel, Switzerland, following its planned separation from its current parent company.
Sandoz, which is due to be spun off from the Swiss pharmaceutical giant in the second half of 2023, said it expects to move from the Novartis campus to its new headquarters in mid-2024.
Write to Adria Calatayud at adria.calatayud@dowjones.com
(END) Dow Jones Newswires
June 01, 2023 02:00 ET (06:00 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Novartis Chart |
1 Month Novartis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
